Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China

BACKGROUND: China is one of the high-burden countries for multidrug-resistant tuberculosis (MDR-TB), and pyrazinamide is one of the anti-TB drugs used for the shorter MDR-TB treatment regimen. The aim of this study was to determine the correlation between pncA gene mutations and resistance to four f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhimin, Lan, Yuanbo, Chen, Ling, Xiang, Min, Peng, Zhiyuan, Zhang, Jianyong, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777635/
https://www.ncbi.nlm.nih.gov/pubmed/31686870
http://dx.doi.org/10.2147/IDR.S222943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777635/
https://www.ncbi.nlm.nih.gov/pubmed/31686870
http://dx.doi.org/10.2147/IDR.S222943

Ejemplares similares